CEVI CellaVision AB (publ)

STO · SE · Healthcare · Medical Devices · cellavision.com

169.20SEK+0.36%Mkt Cap: 384.65M $P/E: 31.16Today

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap384.65M USD

Enterprise Value373.18M USD

Revenue (TTM)70.70M USD

Gross Profit49.73M USD

Net Income (TTM)14.64M USD

Revenue/Share30.99 SEK

Last Price169.20 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees251

CountrySE

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)31.16

P/E (Forward)20.51

PEG—

EV/EBITDA20.97

EV/Revenue5.28

P/S5.44

P/B4.54

EPS (TTM)5.41

EPS (Forward)8.22

52W Range

117.6069% of range192.20

52W High192.20 SEK

52W Low117.60 SEK

Profitability

Gross Margin68.50%

Oper. Margin20.61%

EBITDA Margin25.17%

Profit Margin20.17%

ROE17.25%

ROA13.98%

Growth

Revenue Growth4.50%

Earnings Growth-13.20%

Cash Flow & Leverage

Operating CF19.18M USD

CapEx (TTM)8.25M USD

FCF Margin8.65%

FCF Yield1.59%

Net Debt-11.47M USD

Net Debt/EBITDA-0.64

Balance Sheet

Debt/Equity0.03

Current Ratio3.31

Quick Ratio2.33

Book Value/Sh37.14 SEK

Cash/Share7.22 SEK

Dividends

Fwd Div Rate2.75 SEK

Trail. Div Rate2.75 SEK

Div. Yield1.63%

5Y Avg Yield0.73%

Payout Ratio50.83%

Ex-Div DateApr 29, 2026

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)180.00 SEK

Upside (mean)+6.4%

Target Range160.00 SEK – 200.00 SEK

160.00+6.4% to mean200.00

# Analysts3

Ownership

Shares Out.23.85M

Float19.50M

Insiders18.94%

Institutions70.59%

Technical

SMA 50159.96 (+5.8%)

SMA 200147.22 (+14.9%)

Beta0.98

S&P 52W Chg14.58%

Avg Vol (30d)29.05K

Avg Vol (10d)24.40K

Technical Indicators

RSI (14)55.1

MACD3.8488

MACD Signal3.7664

MACD Hist.+0.0824

BB Upper176.78 SEK

BB Middle166.19 SEK

BB Lower155.60 SEK

BB Width12.75%

ATR (14)4.949 SEK

Vol Ratio (20d)0.35x